Beall C J, Mahajan S, Kuhn D E, Kolattukudy P E
Neurobiotechnology Center, Ohio State University, Columbus 43210, USA.
Biochem J. 1996 Jan 15;313 ( Pt 2)(Pt 2):633-40. doi: 10.1042/bj3130633.
Monocyte chemoattractant protein-1 (MCP-1) mediates monocyte migration into tissues in inflammatory diseases and atherosclerosis. We have investigated structure-activity relationships for human MCP-1. Mutations were introduced based upon differences between MCP-1 and the structurally related but functionally distinct molecule interleukin-8 (IL-8). Mutant proteins produced using the baculovirus/insect cell expression system were purified and their ability to stimulate monocyte chemotaxis and elevation of intracellular calcium in THP-1 monocytic leukaemia cells was measured. Two regions in MCP-1 were identified as important for its biological activity. One region consists of the sequence Thr-Cys-Cys-Tyr (amino acids 10-13). Point mutations of Thr-10 to Arg and Tyr-13 to Ile greatly lowered MCP-1 activity. The second functionally important region is formed by Ser-34 and Lys-35. Insertion of a Pro between these two residues, or their substitution by the sequence Gly-Pro-His, caused nearly complete loss of MCP-1 activity. Competition binding experiments showed that the mutations that affected activity also lowered the ability to compete with wild-type MCP-1 for receptors on THP-1 cells. Point mutations at positions 8, 15, 30, 37, 38 and 68 had little effect on MCP-1 activity. The important regions that we have identified in MCP-1 correspond with previously identified functionally important regions of IL-8, suggesting that the two molecules bind to their respective receptors by similar contacts.
单核细胞趋化蛋白-1(MCP-1)在炎症性疾病和动脉粥样硬化中介导单核细胞向组织内迁移。我们已经研究了人MCP-1的构效关系。基于MCP-1与结构相关但功能不同的分子白细胞介素-8(IL-8)之间的差异引入突变。使用杆状病毒/昆虫细胞表达系统产生的突变蛋白被纯化,并测定它们刺激单核细胞趋化以及提高THP-1单核细胞白血病细胞内钙水平的能力。MCP-1中的两个区域被确定对其生物学活性很重要。一个区域由序列Thr-Cys-Cys-Tyr(氨基酸10 - 13)组成。Thr-10突变为Arg以及Tyr-13突变为Ile大大降低了MCP-1活性。第二个功能重要区域由Ser-34和Lys-35形成。在这两个残基之间插入一个Pro,或者将它们替换为序列Gly-Pro-His,导致MCP-1活性几乎完全丧失。竞争结合实验表明,影响活性的突变也降低了与野生型MCP-1竞争THP-1细胞上受体的能力。第8、15、30、37、38和68位的点突变对MCP-1活性影响很小。我们在MCP-1中确定的重要区域与先前在IL-8中确定的功能重要区域相对应,这表明这两个分子通过相似的接触方式与其各自的受体结合。